PinCell
AcquiredInnovation in dermatology
Italy · $1.8M raised
- Employees
- 1–10
- Business Model
- B2B
- Website
- pincell.it
- Total Funding
- $1.8M
- Last Round
- $1.8M SeedMay 2021
- Rounds
- 1
About
PinCell is a pre-clinical stage biotechnology company based in Italy focused on the development of novel anti-inflammatory therapies for rare and severe dermatological diseases with high unmet medical need. The company targets novel pathological pathways to develop first-in-class treatments for orphan skin diseases, leveraging the expertise of co-founder and CMO Professor Carlo Pincelli.
Summary
PinCell is a Biotech company based in Italy. It has raised $1.8M in total across 1 round, most recently a $1.8M Seed round in May 2021. Investors include Sofinnova Partners.
Sign up to view the funding chart
Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Mar 2025
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...

Global fertility clinics platform
Biopharmaceutical services company

Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.